Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PrEP_COVID: Hydroxychloroquine Pre-Exposure Prophylaxis in High-Risk Healthcare Workers
2020-001565-37Phase 3Active
- Sponsor
- Barcelona Institute for Global Health
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Hydroxychloroquine PrEP with Placebo (2 arms). Primary endpoint: Primary: Confirmed COVID-19 cases during 6-month follow-up. Started Apr 2020; status: active.
02
Drugs
hydroxychloroquine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-001565-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001565-37.